A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer. - Sebastian, Martin; Schröder, Andreas; Scheel, Birgit; Hong, Henoch S.; Muth, Anke; von Boehmer, Lotta; Zippelius, Alfred; Mayer, Frank; Reck, Martin; Atanackovic, Djordje; Thomas, Michael; Schneller, Folker; et al. (Cancer Immunology, Immunotherapy, 2019)